We use our world-class expertise and modern manufacturing infrastructure to develop generic APIs, generic intermediates and xanthine derivatives for the pharmaceutical and food/beverages industry. We have our own backward-integrated intermediaries for most of the APIs that are manufactured. Our products are exported to regulated markets across the globe including the USA, and several countries in the European Union and Japan. We offer CDMO services for drug substance/NCE development and manufacturing focusing on Ph-I/II/III, launch and commercial phases for Innovator pharmaceutical and Biotech companies.